Skip to main content

Table 1 Comparison between the three groups of patients and the control group as regards laboratory data using the Kruskal-Wallis test

From: Role of serum Nogo-B as a biomarker for diagnosis of chronic liver diseases and its severity

Variables

 

Group І (n = 24)

Group II (n = 24)

Group III (n = 24)

Control (n = 18)

P1

P2

Hematemesis and melena

 

21

15

6

   

Bleeding tendency

 

2

4

7

   

Hepatic encephalopathy

 

0

2

8

   

Jaundice

 

0

5

17

   

Ultrasound findings

Hepatomegaly

20

21

6

   

Liver cirrhosis

19

24

24

   

Splenomegaly

20

23

23

   

Ascites

3

21

24

   

Varices (upper GI endoscopy)

 

18

24

24

   

HB

 

8.36 ± 2.26

8.09 ± 1.48

9.04 ± 2.17

12.49 ± 1.98

< 0.001

0.338

PLT

 

122.75 ± 89.33

113.00 ± 70.54

103.75 ± 62.60

302.00 ± 63.24

< 0.001

0.850

Urea

 

45.46 ± 28.14

57.67 ± 30.67

56.54 ± 24.23

30.44 ± 5.76

< 0.001

0.159

Creatinine

 

0.91 ± 0.32

1.05 ± 0.25

1.26 ± 0.41

1.02 ± 0.17

0.800

0.004

Na

 

138.04 ± 3.09

136.46 ± 3.66

134.96 ± 5.86

139.83 ± 3.54

0.004

0.045

ALT

 

30.25 ± 35.15

32.54 ± 17.18

60.87 ± 58.49

23.06 ± 7.30

0.048

< 0.001

AST

 

41.12 ± 31.01

51.88 ± 28.04

100.63 ± 93.31

24.11 ± 7.31

< 0.001

< 0.001

Alb

 

3.28 ± 0.46

2.75 ± 0.30

2.21 ± 0.43

4.93 ± 0.57

< 0.001

< 0.001

Bil

 

.89 ± 0.43

1.43 ± 0.66

3.37 ± 2.21

0.96 ± 0.17

0.026

< 0.001

PC

 

69.92 ± 10.34

59.12 ± 11.98

47.67 ± 14.47

91.28 ± 7.34

< 0.001

< 0.001

Ferritin

 

61.52 ± 129.04

45.06 ± 60.87

44.48 ± 54.71

25.80 ± 19.45

0.525

0.882

Positive anti-bilharzial ab

 

12

17

11

   
  1. HB hemoglobin, TLC total leukocytic count, PLT platelets, Na sodium, K potassium, ALT alanine transaminase, AST aspartate transaminase, Alb albumin, Bil bilirubin, PC prothrombin concentration, PT prothrombin time, P1 between all patients and controls, P2 between the different groups of patients